Haffkine Bio-Pharmaceutical Corporation Ltd. Sustainability Profile
Haffkine Bio-Pharmaceutical Corporation Ltd., commonly referred to as Haffkine, is a prominent player in the biopharmaceutical industry, headquartered in Mumbai, India. Established in 1899, the company has a rich history of innovation and excellence, particularly in the fields of vaccine production and biopharmaceuticals. Haffkine is renowned for its core products, which include vaccines for various infectious diseases, as well as a range of diagnostic kits and therapeutic solutions. The company’s commitment to quality and affordability sets it apart in a competitive market. With a strong presence across India and significant operational reach in international markets, Haffkine has achieved notable milestones, including recognition for its contributions to public health. As a trusted name in the biopharmaceutical sector, Haffkine continues to play a vital role in advancing healthcare solutions.
DitchCarbon Score
How does Haffkine Bio-Pharmaceutical Corporation Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Haffkine Bio-Pharmaceutical Corporation Ltd.'s score of 14 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Haffkine Bio-Pharmaceutical Corporation Ltd.'s reported carbon emissions
Haffkine Bio-Pharmaceutical Corporation Ltd., headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Haffkine may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, Haffkine's future climate commitments will be crucial for aligning with global standards and expectations.
How Carbon Intensive is Haffkine Bio-Pharmaceutical Corporation Ltd.'s Industry?
How Carbon Intensive is Haffkine Bio-Pharmaceutical Corporation Ltd.'s Location?
Haffkine Bio-Pharmaceutical Corporation Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Haffkine Bio-Pharmaceutical Corporation Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
